Safety of Neurostar TMS Therapy
Fewer than 5% of patients discontinued treatment with NeuroStar TMS Therapy due to adverse events. Over 10,000 active treatments were performed across all NeuroStar® clinical trials demonstrating its safety. Contact the professionals at ABHC in Seattle, Bellevue or Kent to find out more about this groundbreaking, non-invasive, and effective treatment option for depression.
Neurostar TMS Therapy is safe and easy to tolerate. Because it is not a depression drug, this therapy does not share the same side affects often associated with antidepressant medications.
The most common side effect reported during clinical trials was scalp discomfort—generally mild to moderate and occurring less frequently after the first week of treatment.
- No systemic side effects
- No weight gain
- No sexual dysfunction
- No sedation
- No nausea
- No dry mouth
- No adverse effects on concentration or memory
- No drug interactions
- NeuroStar TMS Therapy should not be used in patients with implanted metallic devices or non-removable metallic objects in or around the head. This does not include metallic fillings in teeth.
- NeuroStar TMS Therapy should not be used in patients with implants controlled by physiological signals. This includes pacemakers, implantable cardioverter defibrillators (ICDs), and vagus nerve stimulators (VNS).